Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Tonix Pharmaceuticals Holding Corp’s current trading price is -99.32% away from its 52-week high, while its distance from the 52-week low is 27.12%. The stock’s price range over this period has fluctuated between $0.12 and $22.14. The company, operating within the financial sector, had a trading volume of approximately 8.32 million for the day, which was noticeably lower than the average daily share volume of 26.45 million over the last 3 months.
Tonix Pharmaceuticals Holding Corp experienced a rather shaky stock market performance. The highest value in the past year was recorded at $22.14 on 12/19/23 and the lowest value was $0.12 on 10/03/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -75.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.59M and boasts a workforce of 103 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0543, with a change in price of -5.7380. Similarly, Tonix Pharmaceuticals Holding Corp recorded 17,987,133 in trading volume during the last 100 days, posting a change of -97.45%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TNXP stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.15.
TNXP Stock Stochastic Average
Today’s raw stochastic average for Tonix Pharmaceuticals Holding Corp over the last 50 days is 4.40%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 33.90%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 29.66% and 27.73%, respectively.
TNXP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -98.84% this year. Over the last six months, there has been a stronger performance of -96.79%. The price of TNXP leaped by -4.34% during the last 30 days period. For the last 5-days stocks have improved 4.24%.
